Back to Search
Start Over
Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase
- Source :
- Advances in Therapy
- Publication Year :
- 2020
- Publisher :
- Springer Healthcare, 2020.
-
Abstract
- Introduction Increasing dialysate magnesium (D-Mg2+) appears to be an intriguing strategy to obtain cardiovascular benefits in subjects with end-stage kidney disease (ESKD) on hemodialysis. To date, however, hemodialysis guidelines do not suggest to increase D-Mg2+ routinely set at 0.50 mmol/L. Methods A randomized 4-week crossover study aimed at investigating the consequences of increasing D-Mg2+ from 0.50 to 0.75 mmol/L on arterial stiffness, hemodynamic profile, and endothelial function in subjects undergoing hemodialysis. The long-term effect of higher D-Mg2+ on mineral metabolism markers was investigated in a 6-month follow-up. Data were analyzed by linear mixed models for repeated measures. Results Data of 39 patients were analyzed. Pulse wave velocity and pulse pressure significantly decreased on the higher D-Mg2+ compared with the standard one by − 0.91 m/s (95% confidence interval − 1.52 to − 0.29; p = 0.01) and − 9.61 mmHg (− 18.89 to − 0.33, p = 0.04), respectively. A significant reduction in systolic blood pressure of − 12.96 mmHg (− 24.71 to − 1.22, p = 0.03) was also observed. No period or carryover effects were observed. During the long-term follow-up phase the higher D-Mg2+ significantly increased ionized and total serum Mg (respectively from 0.54 to 0.64 and from 0.84 to 1.07 mmol/L; mean percentage change from baseline to follow-up + 21% and + 27%; p ≤ 0.001), while parathormone (PTH) decreased significantly (from 36.6 to 34.4 pmol/L; % change − 11%, p = 0.03). Conclusions Increasing dialysate magnesium improves vascular stiffness in subjects undergoing maintenance hemodialysis. The present findings merit a larger trial to evaluate the effects of 0.75 mmol/L D-Mg2+ on major clinical outcomes. Trial Registration The study was retrospectively registered on the ISRCTN registry (ISRCTN 74139255) on 18 June 2020.
- Subjects :
- Adult
Male
medicine.medical_specialty
Magnesium Hydroxide
Dialysate magnesium
medicine.medical_treatment
Hemodynamics
Administration, Oral
Blood Pressure
Pulse Wave Analysis
Vascular endothelial function
Vascular Stiffness
Renal Dialysis
Internal medicine
Dialysis Solutions
Medicine
Humans
Pharmacology (medical)
Pulse wave velocity
Original Research
Aged
Cross-Over Studies
business.industry
Repeated measures design
General Medicine
Middle Aged
medicine.disease
Crossover study
Arterial stiffness
Pulse pressure
Blood pressure
Cardiology
Kidney Failure, Chronic
Calcium
Female
Hemodialysis
business
Biomarkers
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 18658652 and 0741238X
- Volume :
- 37
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Advances in Therapy
- Accession number :
- edsair.doi.dedup.....12a1fa3fa0bd3c105f5bfab085e53c1b